In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Selpercatinib is a highly selective RET inhibitor that inhibits the growth of tu···【more】
Release date:2024-08-16Recommended:216
Selpercatinib is the first targeted drug specifically targeting RET gene mutatio···【more】
Release date:2024-08-16Recommended:184
In May 2020, Selpercatinib was approved by the FDA for the treatment of various ···【more】
Release date:2024-08-16Recommended:254
Selpercatinib treats cancer patients by specifically inhibiting RET kinase activ···【more】
Release date:2024-08-16Recommended:208
Selpercatinib helps control the proliferation and metastasis of cancer cells by ···【more】
Release date:2024-08-16Recommended:290
As a highly selective RET inhibitor, Selpercatinib is used for the treatment of ···【more】
Release date:2024-08-16Recommended:225
The commonly used dosage form of Mitotane is a tablet, which is an antineoplasti···【more】
Release date:2024-08-16Recommended:205
Selpercatinib is a targeted drug that specifically targets mutations in the RET ···【more】
Release date:2024-08-16Recommended:215
By inhibiting the synthesis of adrenocortical hormones, Mitotane slows or stops ···【more】
Release date:2024-08-16Recommended:241
Mitotane is a drug with a unique mechanism of action that plays an important rol···【more】
Release date:2024-08-16Recommended:242
The price of Mitotane has always been a focus of concern for patients and famili···【more】
Release date:2024-08-16Recommended:290
Mitotane is a specific drug for the treatment of adrenocortical carcinoma (ACC),···【more】
Release date:2024-08-16Recommended:285